DonSDizonMDFACP(he/him)

PubMed

• 48 citations
  Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement.
  David P. Al-Adra, Laura L. Hammel, John P. Roberts, E. Steve Woodle, Deborah Levine
  American Journal of Transplantation. 2021-02-01
• 70 citations
  Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement.
  David P. Al-Adra, Laura L. Hammel, John P. Roberts, E. Steve Woodle, Deborah Levine
  American Journal of Transplantation. 2021-02-01
• 3 citations
  Opposing Roles ofMutations in Human Prostate and Endometrial Cancers.
  Ludimila Cavalcante, Sachin Kumar Deshmukh, Jennifer R Ribeiro, Benedito A Carneiro, Don S Dizon
  JCO Precision Oncology. 2023-09-01

Journal Articles

• Investigator Use of Social Media for Recruitment of Patients for Cancer Clinical Trials  
  Mina S Sedrak, Don S Dizon, JAMA Network Open
• Dyspareunia and vaginal dryness after breast cancer treatment.  
  DL Wiggins and DS Dizon, Sexuality, Reproduction, and Menopause, 2008: 18-22
• Stage IV small bowel carcinoma mimicking advanced ovarian cancer: case report and review of the literature.  
  DS Dizon, K Perez, P DiSilvestro, C Taneja, D Ilson, American Surgeon 2009; 75:864-5
• The differential diagnosis of dyspnea in a woman with metastatic breast cancer: Consideration beyond pulmonary embolism.  
  DS Dizon, J Beheshti, K McDonough, J Gass, The Breast Journal, 2008; 14:90-1
• Ovarian cancer associated with testosterone supplementation in a female-to-male transsexual patient.  
  DS Dizon, T Tejada-Berges, S Koelliker, M Steinhoff, and CO Granai, J Gynecol and Obstet Invest 2006; 62:226-228
• Anti-mitotic inhibitors.  
  Campos SM and Dizon DS, Hematology and Oncology clinics 2012; 26: 607-628
• New advances in the treatment of endometrial cancer.  
  Roque DR and Dizon DS, Clin Invest 2011; 1:413-422
• Breast cancer: adjuvant modalities.  
  Sakr BJ and Dizon DS, Clin Obstet Gynecol 2011; 54:150-6
• HER-Dimerization Inhibitors: Evaluating pertuzumab in women’s cancers.  
  K Kristjansdottir and DS Dizon, Expert Opinion on Biologic Therapy. 2010; 10:243-50
• Sexual ramifications of medical illness.  
  K. Perez, M Gadgil, and DS Dizon, Clinics of Obstetrics and Gynecology 2009; 52:691-701
• Sexuality and intimacy following cancer.  
  MA Kunz and DS Dizon, US Obstetrics & Gynecology 2009; 3:21-23
• Breast Cancer Follow-Up; Extending the focus beyond survival.  
  S MacLaughlan and DS Dizon, Journal Watch Women’s Health, March 2009; 14:19-20
• HER dimerization inhibitors: Developing pertuzumab as an anti-cancer agent in women’s oncology.  
  DS Dizon and S Makhija, Expert Opinion in Drug Discovery, 2008; 11:1363-69
• Short Communication: Palmar-plantar erythrodysesthesia is not related to body mass index in patients receiving pegylated liposomal doxorubicin.  
  ME Gordinier, DS Dizon, EL Fleming, S Weitzen, CO Granai, Gynecol Oncol 2006; 103:72-4
• Personalizing chemotherapy through genetic profiling: will pharmacogenomics help improve and extend life for cancer patients?  
  K Hachey and DS Dizon, Personalized Medicine, 2009; 6:481-4
• New generation platinum agents for solid tumors.  
  N Shah and DS Dizon, Future Medicine 2009; 5:33-42
• Regional chemotherapy: a focus on hepatic artery infusion for colorectal cancer liver metastases.  
  DS Dizon, J Schwartz, N Kemeny, Surg Oncol Clin N Am, 2008; 17:759-71
• Intrahepatic arterial infusion of chemotherapy: clinical results.  
  DS Dizon and N Kemeny, Sem in Oncol 2002; 29:126-135
• Management of ovarian cancer: balancing therapy and quality of life.  
  DS Dizon and PJ Sabbatini, Oncol Spec Ed. 2002; 5:1-6
• Is Tumor Board Relevant?  
  Rizack T, Gass JS, Legare RD, Sakr BJ, Dizon DS, The Breast Journal
• A phase II study of patupilone (EPO906) in patients with platinum-resistant or –refractory ovarian cancer.  
  Smit WM, Sufliarsky J, Werner TL, Dizon DS, Wagnerova M, Hirte HW, Spiritos NM, Oza A, Dirix L, El-Hasimy M, Acharyya S, Tan EY, Weber D, and Schellens JHM, Clin Ovarian Cancer and Other Gynecologic Cancers
• Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Treated Ovarian Cancer.  
  DS Dizon, L Damstrup, NJ Finkler, U Lassen, P Celano, R Glasspool, E Crowley, HS Lichenstein, P Knoublach, RT Penson, Inter Journal of Gynecol Cancer 2012; 22:979-86
• Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva.  
  Horowitz NS, Olawaiye AB, Borger DR, Growdon WB, Krasner CN, Matulonis UA, Liu JF, Lee J, Brard L, and Dizon D, Gyn Oncol 2012; 127:141-6
• Locally advanced vulvar cancer in elderly women: is chemoradiation beneficial?  
  A Stuckey, M Schutzer, T Rizack, and DS Dizon, Am J Clin Oncol 2012; Epub Ahead of print
• Evaluation of belinostat and carboplatin in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma: a Gyn...  
  Dizon DS, Blessing JA, Penson RT, Drake RD, Walker JL, Johnston CM, Disilvestro PA, Fader AN, Gyn Oncology 2012; 125:367-371
• Join now to see all

Books/Book Chapters

• Precis: an Update in Obstetrics and Gynecology. 
  Chapter: Long term quality of life and symptoms management for women with cancer 
  Page 126 - 138RT Penson and DS DizonEditors: JS Berek, et al.American College of Obstetrics & Gynecology, Washington, DCEdition 3,
• Atlas of Cancer. 
  Chapter: Management of Non-Epithelial Ovarian Cancers 
  Page 100 - 105DS Dizon, E Poynor, and ML HensleyEditors: M Markman.Lippincott, Williams, & Wilkins, Philadelphia
• Colorectal Cancer: A Clinical Guide to Therapy. 
  Chapter: Locoregional Chemotherapy for Metastatic Colorectal Cancer to the Liver 
  Page 367 - 374DS Dizon and N KemenyEditors: Bleiberg M, Kemeny N, Rougier PH, Wilke HJ.Martin Dunitz, London
• Colorectal Cancer: A Clinical Guide to Therapy. 
  Chapter: Adjuvant Chemotherapy After Hepatic Resection for Metastatic Colorectal Carcinoma 
  Page 359 - 366N Kemeny and DS DizonEditors: Bleiberg M, Kemeny N, Rougier PH, Wilke HJ.Martin Dunitz
• Gene Therapy of Cancer: Methods and Protocols. 
  Chapter: Methods for Chemoprotection and Chemo-sensitization: MDR-1 For Chemoprotection Using Retroviruses to Modify Hematopoietic Cells and Cytosine Deaminase for Chemosensitization Using Adenoviral Vectors 
  Page 609 - 616S Srimdkandada, T Fujii, T Wang, SQ Fu, LH Yin, XYD Guo, T Nanakorn, XY Peng, WL Wang, L Zhang, A Canaan, M Anderson, D Dizon, D Lin, M Cooperberg, R Loewe, S Savinov,...Editors: W. Walther, and U. Stein.Humana Press, Totowa, New Jersey
• Cancer and Sexual Health. 
  Chapter: Evaluation of the female with sexual dysfunction 
  ML Krychman, D Dizon, A Amsterdam, S Kellogg SpadtEditors: JP Mulhall, L Incrocci, I Goldstein, R Rosen.SpringerLink, New York
• The European Society of Gynecologic Oncologists’ Handbook for Fellows in Gynecologic Oncology. 
  Chapter: Choosing treatments for recurrent ovarian cancer: the platinum-free interval 
  A Stuckey and DS DizonEditors: M. Gultekin.Edition 2,
• The European Society of Gynecologic Oncologists’ Handbook for Fellows in Gynecologic Oncology. 
  Chapter: Choosing treatments for recurrent ovarian cancer: the platinum-free interval 
  A Stuckey and DS DizonEditors: M. Gultekin.
• Principles and Practice of Gynecologic Oncology. 
  Chapter: Breast Cancer 
  DS Dizon, T Tejada-Berges, MM Steinhoff, CJ Sung, S Koelliker, HI Khalil, B O’Connor, S MacAusland, C Taneja, RD Legare, and JS GassEditors: Barakat, Markman, and Randall.Lippincott Williams and Wilkins
• Female Sexual Pain Disorders: Evaluation and Management. 
  Chapter: Cancer and Dyspareunia 
  MA Krychman, DS Dizon, A Amsterdam, A PartridgeEditors: Goldstein, Pukall, and Goldstein.Blackwell, Towson
• Principles & Practice of Cancer Rehabilitation. 
  Chapter: Sexuality 
  DS Dizon and M KrychmanEditors: M Stubblefield, M O’Dell, C Custodio, and T Fitzpatrick.Demos, New York
• DxRx Cervical Cancer: An approach to preinvasive and invasive malignancies of the cervix. 
  K Robison and DS DizonJones and Bartlett, Sudbury, MA
• Chemotherapy for Gynecologic Neoplasms: Current Therapy and Novel Approaches. 
  Chapter: Persistent and recurrent ovarian cancer 
  Page 407 - 432DS Dizon and DR SpriggsEditors: Penalver M, Angioli R, Panici PB, Kavanagh J, Pecorelli S.Dekker, New York
• Cancer Drug Discovery and Development: Combination Cancer Therapy: Modulators and Potentiators. 
  Chapter: Targeting NF-kB to increase the actibity of cisplatin in solid tumors 
  Page 197 - 207DS Dizon, C Aghajanian, XJ Yan, D SpriggsEditors: Schwartz, G.K.Humana Press, Totowa, NJ
• Atlas of Cancer. 
  Chapter: Management of Non-Epithelial Ovarian Cancers 
  Page 100 - 105DS Dizon, E Poynor, and ML HensleyEditors: M Markman.Lippincott, Williams, & Wilkins, Philadelphia
• Colorectal Cancer: A Clinical Guide to Therapy. 
  Chapter: Locoregional Chemotherapy for Metastatic Colorectal Cancer to the Liver 
  Page 367 - 374DS Dizon and N KemenyEditors: Bleiberg M, Kemeny N, Rougier PH, Wilke HJ.Martin Dunitz, London
• Colorectal Cancer: A Clinical Guide to Therapy. 
  Chapter: Adjuvant Chemotherapy After Hepatic Resection for Metastatic Colorectal Carcinoma 
  Page 359 - 366N Kemeny and DS DizonEditors: Bleiberg M, Kemeny N, Rougier PH, Wilke HJ.Martin Dunitz, London
• A Methods for Chemoprotection and Chemo-sensitization: MDR-1 For Chemoprotection Using Retroviruses to Modify Hematopoietic Cells and Cytosine Deaminase for Chemosensitization Using Adenoviral Vectors 
  Page 609 - 616S Srimdkandada, T Fujii, T Wang, SQ Fu, LH Yin, XYD Guo, T Nanakorn, XY Peng, WL Wang, L Zhang, A Canaan, M Anderson, D Dizon, D Lin, M Cooperberg, R Loewe, S Savinov,...Editors: W. Walther, and U. Stein.Humana Press, Totowa, New Jersey
• DxRx Cervical Cancer: An approach to preinvasive and invasive malignancies of the cervix. 
  K Robison and DS DizonJones and Bartlett, Sudbury, MAEdition 2,
• DxRx Gynecologic Cancers. 
  SM Campos and DS DizonJones and Bartlett, Sudbury, MA
• Gynecologic Tumor Board: Clinical Cases in the Diagnosis and Management of Cancer of the Female Reproductive System. 
  DS DizonEditors: DS Dizon and NA Rustum.Jones and Bartlett, Sudbury, MA
• Join now to see all

Abstracts/Posters

• Continuing the mission for Interdisciplinary Breast Care.
  J Gass and DS Dizon, 2007 National Consortium of Breast Centers Annual Meeting. RT Image Magazine
• Breast Center Evolution.
  Don S. Dizon and Constance A. Roche, NCBC Annual Meeting 2007. Am J Clin Onc, 2007; 30:444-60, The 17th Annual National Interdisciplinary Breast Center Conference
• Breast care in 2011 and beyond: State of Policy, State of Science.
  Gass JS, Bell J, Dizon DS, Expert Rev Anticancer Ther 2011; 6:837-39
• Endometrial cancer: Present state and future promise.
  DS Dizon, KH Lu, and DS Miller, 2011 Educational Book. American Society of Clinical Oncology
• A comparison of gene expression analyses in SKOV-3 wild-type and resistant ovarian carcinoma cells following treatment with cisplatin and a non-cross-resistant platinu...
  DS Dizon, XJ Yan, DR Spriggs, American Association for Cancer Research, 92nd Annual Meeting, New Orleans, LA
• Carboplatin and paclitaxel as initial second line therapy in women with recurrent epithelial ovarian cancer.
  DS Dizon, M Hensley, P Sabbatinni, C Aghajanian, E Poynor, E Venkatraman, A Hummer, DR Spriggs, American Society of Clinical Oncology Annual Meeting 2001. San Francisco, CA
• A Phase I Trial of the Novel Proteasome Inhibitor PS341 in Advanced Solid Tumor Malignancies.
  C Aghajanian, S Soignet, DS Dizon, S Pezzulli, A Daud, DR Spriggs, J Adams, P Elliott, C Pien, American Society of Clinical Oncology Annual Meeting 2001. San Francisco, CA
• Platinum retreatment of platinum refractory ovarian cancer after non-platinum therapy.
  DR Spriggs, M Letaio, A Hummer, DS Dizon, P Sabbatini, C Aghajanian, M Hensley, E Venkatraman, American Society of Clinical Oncology Annual Meeting 2002. Orlando, FL
• CO2 pneumoperitoneum does not reduce the survival of women with persistent metastatic ovarian cancer.
  NR Abu-Rustum, Y Sonoda, DS Chi, DS Dizon, E Venkatraman, RR Barakat, Society of Gynecologic Oncologists 34th Annual Meeting. New Orleans, LA
• Phase I trial of PS-341 and carboplatin in recurrent ovarian cancer.
  C. Aghajanian, D Dizon, XJ Yan, J Raizer, P Sabbatini, S Pezzulli, A Philip, S Anderson, J Dupont, DR Spriggs, American Society of Clinical Oncology Annual Meeting 2003. Chicago, IL
• Second responses to gemcitabine-based therapy in uterine leiomyosarcomas.
  S Anderson, C Aghajanian, P Sabbatini, RG Maki, DS Dizon, J Dupont, Y Sonoda, MM Leitao, D Spriggs, American Society of Clinical Oncology Annual Meeting 2003. Chicago, IL
• The utilization of an Integrative Medicine Program by Female Cancer Patients in an Academic Cancer Center.
  D Wiggins, J Gass, D Buchanan, A Goldstein, CO Granai, D Dizon, National Consortium of Breast Centers Annual Meeting 2004. Las Vegas, NV
• The Cancer Risk Assessment and Prevention Program (CRAPP) Database enhances practical management and promotes clinical research of patient data within a cancer genetic...
  JS Wilbur, MK McDonnell, DS Dizon, RD Legare, National Consortium of Breast Centers Annual Meeting 2004. Las Vegas, NV
• Phase I trial of BMS-247550 and Gemcitabine in patients with advanced solid tumor malignancies.
  S Anderson, D Dizon, P Sabbatini, J Dupont, S Pezzulli, A Massey, C Aghajanian, Proceedings of the American Society of Clinical Oncology Annual Meeting 2004. New Orleans, LA
• Does body mass index predict cutaneous reactions to pegylated liposomal doxorubicin?
  EL Fleming, DS Dizon, PA DiSilvestro, RG Moore, C Granai, ME Gordinier, American Society of Clinical Oncology Annual Meeting 2004. New Orleans, LA
• Two for good measure: Six versus eight cycles of Carboplatin and Paclitaxel as treatment for epithelial ovarian cancer.
  DS Dizon, A Rojan, T Tejada-Berges, P DiSilvestro, M Gordinier, R Moore, A Bradley, S Weitzen, R Legare, CO Granai, Society of Gynecologic Oncologists Annual Meeting 2005. Miami Beach, FL
• Cross-sensitivity between Paclitaxel and Docetaxel in a Women's Cancers Program.
  DS Dizon, A Rojan, J Miller, J Schwartz, ME Gordinier, L Pires, P DiSilvestro, R Moore, CO Granai, J. Gass, R. D. Legare, American Society of Clinical Oncology 2005. Orlando, FL
• Kids Talk: Implementation of a Safe Place for the Children of Caregivers with Cancer.
  C Dieterich, S Morrey, DS Dizon, R Strenger, CO Granai, R Cohen, D Thompson, American Society of Clinical Oncology. Orlando, FL
• Frequent pathologic complete responses seen with neoadjuvant q4week carboplatin and weekly paclitaxel + weekly trastuzumab in resectable and locally advanced breast ca...
  M A Fenton, MD, L M Ries, MD, R S Strenger, MD, D S Dizon, MD, R D Legare, MD, P J Joseph, MD, K P Theall, MD, T A Graves, MD, J S Gass, MD and W M Sikov, MD, San Antonio Breast Cancer Symposium 2005. San Antonio, TX
• Concordance between preoperative assessment of T1 cancers and pathologic results: considerations for ablative therapy.
  J Gass, DL Wiggins, M Steinhoff, SL Koelliker, and DS Dizon, National Consortium of Breast Centers Annual Meeting. Las Vegas, NV
• Neoadjuvant q4week carboplatin (Cb) and weekly paclitaxel (P) + weekly Trastuzumab (Trastuzumab, H) induces a high pathologic response (pCR) rate in resectable and loc...
  WM Sikov, MA Fenton, DS Dizon, R Strenger, RD Legare, PJ Joseph, KP Therall, TA Graves, LM Ries, TA Kennedy, GM Strauss, and JS Gass, National Consortium of Breast Centers Annual Meeting. Las Vegas, NV
• Clinical Significance of 2+ HER-2/neu expression in patients having various underlying molecular cytogenetic abnormalities.
  MR Quddus, CJ Sung, MM Steinhoff, L Rashid, U Tantravahi, R Strenger, R Legare, J Gass, W Sikov, DS Dizon, National Consortium of Breast Centers Annual Meeting. Las Vegas, NV
• Role of US Guided Axillary FNA in the Management of Invasive Breast Cancer.
  P Somasundar, J Gass, M Steinhoff, S Koelliker, DS Dizon, B Cady, C Taneja, American Society of Breast Surgeons Annual Meeting. Baltimore, MD
• Clinical correlation of MRI and pathological specimens in surgically treated breast cancer patients.
  C Rizk, DS Dizon, H Khalil, M Steinhoff, JS Gass, American Society of Breast Surgeons Annual Meeting, Baltimore, MD
• Does the platinum-free interval predict severity or incidence of hypersensitivity reactions to Carboplatin? The experience from Women & Infants' Hospital.
  J Schwartz, AM Bradley, C Bandera, L Brard, P DiSilvestro, R Legare, R Moore, T Tejada-Berges, CO Granai, DS Dizon, American Society of Clinical Oncology Annual Meeting, Atlanta, GA
• Join now to see all

Lectures

• New Approaches for Less Studied Tumors 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Fertility and Sexuality. 
  Core Curriculum Seminar, Vanderbilt University School of Medicine, Nashville, TN
• Practice Patterns on the use of intraperitoneal chemotherapy in women with ovarian cancer. 
  Society of Gynecologic Oncologists 39th Annual Meeting. Tampa, FL
• Preparing for survivorship: Quality of life of breast cancer survivors. Assessments and Interventions. 
  International Society for Sexuality and Medicine Symposium, Washington, DC
• Cervical Cancer: Screening and Prevention Sexuality and Fertility: talking with your male and female patients about their options. 
  Sixth Annual Oncology Congress, San Francisco
• Endometrial Cancer: Present State and Future Promise. 
  Annual Meeting of the American Society of Clinical Oncology, Chicago
• Options in the Treatment of relapsed endometrial cancer: beyond first-line therapy. 
  Annual Meeting of the American Society of Clinical Oncology, Chicago
• Medical Oncology Basics. 
  National Consortium of Breast Centers Annual Meeting, Las Vegas
• Screening Mammography in Women Aged 40-49. 
  National Consortium of Breast Centers Annual Meeting, Las Vegas
• New Strategies in the clinical treatment of endometrial cancer. 
  The Chemotherapy Foundation Symposium XXVII, New York City
• Approaching Metastatic Breast Cancer. 
  National Consortium of Breast Centers Annual Meeting, Las Vegas
• Golden Girls: The Approach to Breast Health in Women over 70. 
  National Consortium of Breast Centers Annual Meeting, Las Vegas
• Clinical Advances in Gynecologic Malignancies. 
  Society of Gynecologic Oncologists Annual Meeting, San Francisco
• Current Strategies in the Treatment of Platinum-Resistant Recurrent Ovarian Cancer. 
  Society of Gynecologic Oncologists Annual Meeting, San Francisco
• Challenges in Survivorship. 
  American Society of Clinical Oncology Breast Cancer Symposium, San Francisco
• Moving Beyond Standard of Care: Novel Treatments in Gynecologic Malignancies. 
  Chemotherapy Foundation Symposium, New York City
• Bevacizumab should not be continued indefinitely and utilized with every drug regimen for recurrence. 
  Gynecologic Oncology Group Summer Symposium, Baltimore
• Controversies in Breast Cancer Management. 
  19th Annual Interdisciplinary Breast Conference, Las Vegas
• Recurrent Endometrial Cancer: Chemotherapy. 
  Passe or Je ne sais quoi? Chicago
• Challenges in Survivorship. 
  ASCO Breast Cancer Symposium. Washington, DC
• Families and Breast Cancer: Advance care planning and primary support. 
  National Consortium of Breast Centers. Las Vegas
• Blocking HER Dimerization: Preclinical and Early Clinical Evaluation of Pertuzumab. 
  The Fifth International Congress on Monoclonal Antibodies in Cancer. Quebec City, Canada
• Opening Plenary: Ovarian Cancer. 
  International Gynecologic Cancer Society Biennial Meeting, Vancouver, BC
• Bevacizumab and other biologics for the treatment of epithelial ovarian cancer. 
  Controversies in Obstetrics, Gynecology, and Infertility, Paris, France
• Intravenous chemotherapy should be the first choice for adjuvant treatment for epithelial ovarian cancer. 
  Controversies in Obstetrics, Gynecology, and Infertility, Paris, France
• Join now to see all

Other

• The sexuality clinic in the breast center: sex as a survivorship issue. 
  DS Dizon, CA Duffy, DS Thompson, DL Wiggins, Breast Cancer Online 2008; 1:1-3. doi:10.1017/S`47090310800802X
• Practical guidance: The use of social media. 
  Dizon DS, Graham D, Thompson MA, Johnson L, Johnston C, Fisch M, and Miller R, J Oncol Pract 2012; 8:e114-24
• Breast cancer Task Force SGO Position Paper. 
  J Orr, J Kelley, D Dizon, P Escobar, E Fleming, M Gemignani, D Hetzel, W Hoskins, J Lapolla, S Lwein, J Lucci, M Markman, B Pothuri, B Powell, T Tejada-Berges, L Kilgore, Gynecol Oncol 2008; 110:7-12
• Is there sex for women after cancer. 
  A Katz and DS Dizon, Coping magazine
• Preparing for Survivorship: Quality of Life in Breast Cancer Survivors. 
  Gao J and Dizon DS, Journal of Sex Medicine 2013; 10 (Suppl 1):16-20
• Novel antiangiogenic therapies in ovarian cancer. 
  Stuckey A and Dizon DS, Womens Health (London Engl) 2012; 8:447-53
• Sexual dysfunction in female cancer survivors. 
  DeSimone M, Spriggs E, Gass JS, Carson SA, Krychman ML, and Dizon DS, Am J Clin Oncol
• Medical therapy of endometrial cancer: Current status and promising novel treatments. 
  Hill EK and Dizon DS, Drugs 2012; 26:72:705-13
• Moving Beyond Standard of Care: Novel Treatments in Gynecologic Cancer. 
  K Robison and DS Dizon, Contemporary Oncology
• Treating Locally advanced, Recurrent or Metastatic Endometrial Cancer: A Focus on Ixabepilone. 
  K Kilfoyle and DS Dizon, European Journal of Medical Oncology. 2010; 2:65-70
• Ixabepilone as a second-line treatment in advanced endometrial cancer. 
  N Kawar and DS Dizon, Asian-Pacific Journal of Hematology and Oncology
• Perspective: Help or harm: Adjuvant therapies for primary invasive disease and the risk of a second contralateral breast cancer. 
  DS Dizon and JS Gass, Am Journal of Hemat and Oncol
  http://www.ajho.com/Help-or-harm-Adjuvant-therapies-for-primary-invasive-disease-and-the-risk-of-a-s
• Adjuvant therapy for endometrial cancer: “sandwich therapy” of carboplatin and paclitaxel with radiation therapy. 
  DS Dizon, CK McCourt, T Martin-Hanley, L Brard, AM Bradley, C Bandera, Cancer Therapy, 2007; 5:395-400
  http://www.cancer-therapy.org/articles5B.html
• Sexual dysfunction following breast cancer treatment: common problems, diagnosis, and management. 
  A Kuo, DL Wiggins, and DS Dizon, SRM: Sexuality, Reproduction, and Menopause, 2008; 6:17-20
• Where do anti-angiogenic agents belong in the treatment algorithm for ovarian cancer? 
  DS Dizon, American J Clin Oncol, 2011
• Treatment options for advanced endometrial cancer. 
  DS Dizon, Gynecologic Oncology 2010; 117:373-81
• Quality of life after breast cancer: survivorship and sexuality. 
  DS Dizon, The Breast Journal. 2009; 15:500-4
• Blocking HER dimerization: the clinical development of Pertuzumab in ovarian cancer. 
  DS Dizon, Advances in Ovarian Cancer, 2005: 3-6
• Incorporating targeted treatments into standard regimens: whither the role of established doses? 
  DS Dizon, Cancer Investigation 2004; 6:954
• Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. 
  Ledermann J, Harter P, Gourley C, et al, N Engl J Med 2012; 366:1382
• Randomized, double-blind placebo controlled phase II study of AMG386 combined with weekly paclitaxel in patients with recurrent ovarian cancer. 
  Karlan BY, Oza AM, Richardson GE, Provencher Dm, Hansen VL, Buck M, Chambers SK, Ghatage P, Pippit CH Jr, Brown JV 3rd, Covens A, Nagarkar RV, Davy M, Leath CA 3rd, Ng..., J Clin Oncol 2012; 30:362-71
• Phase II study of bevacizumab in patients with platinum-resistnat ovarian or peritoneal serous cancer. 
  Cannistra SA, Matulonis UA, Penson RT, Hambleton J, Dupont J, Mackey H, Douglas J, Burger RA, Armstrong D, Wenham R, McGuire W, J Clin Oncol 2007; 25:5150-2
• Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. 
  EH Romond, EA Perez, J Bryant, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel V..., New Engl J Med 2005; 353:1673-84
• Join now to see all